天津市2013-2015年MSM HIV感染者病毒载量抽样调查

Sampling survey of viral load among MSM infected with HIV in Tianjin from 2013 to 2015

  • 摘要: 目的 抽样调查2013-2015年天津市男男性行为人群(MSM)艾滋病病毒(HIV)感染者的病毒载量检测结果,获得MSM感染者社区平均病毒载量水平,评估MSM感染者人群的HIV传播能力。方法 从艾滋病综合防治信息系统中随机抽取3年天津市MSM感染者检测名单,采集静脉血进行病毒载量检测,分析检测结果。结果 2013-2015年共完成MSM HIV感染者病例抽样调查556人,每年分别完成MSM感染者病毒载量调查194、178和184人,其中已进行艾滋病抗病毒治疗(ARV)的比例分别为53.6%、63.5%和78.3%; 3年MSM社区抽样调查平均病毒载量结果分别为324、232、189 c/ml,分别对未治疗和治疗者平均病毒载量统计结果为1 759、1 917、4 478 c/ml,75、69、78 c/ml;对3年间病毒载量检测对数值两两比较,在治疗与未治疗组中,病毒载量在各组别中几年间差异无统计学意义。结论 应尽早启动针对MSM HIV感染者的艾滋病抗病毒治疗工作,有助于降低社区平均病毒载量水平,在个体发病和死亡风险降低方面还是在群体水平上降低病毒传播能力方面均具有十分重要意义。

     

    Abstract: OBJECTIVE To analyze the results of sampling survey of viral load among men who have sex with men (MSM) infected with human immunodeficiency virus (HIV) in Tianjin from 2013 to 2015 so as to acquire the average level of viral load of the MSM with the infection and evaluate the transmission of HIV among the MSM population. METHODS The MSM with infection were randomly extracted from the data and information management system for prevention and control of AIDS in Tianjin in three years, then the venous blood samples were collected to detect the viral load, and the detection results were observed. RESULTS A total of 556 MSM with HIV infection were included in the sampling survey from 2013 to 2015; the viral load was detected for 194 MSM with infection in 2013, 178 in 2014, 184 in 2015; 53.6% have received the antiretroviral(ARV) therapy in 2013, 63.5% in 2014, 78.3% in 2015.The result of the community sampling survey of the MSM showed that the average viral load was 324 c/ml in 2013, 232 c/ml in 2014, 189 c/ml in 2015; the viral loads of the MSM who did not receive the ARV therapy were 1 759 c/ml, 1 917 c/ml, and 4 478 c/ml, respectively; the viral loads of the MSM who received the ARV therapy were 75 c/ml, 69 c/ml, and 78 c/ml, respectively; there was between-group difference in the viral load between the treatment group and the non-treatment group in the three years. CONCLUSION It is necessary to carry out the ARV therapy for the MSM with HIV infection as early as possible, which may facilitate the reduction of average level of viral load and has great significance in reducing the morbidity of individuals and risk of death as well as reducing the capability of transmission of the virus.

     

/

返回文章
返回